Director of Biomedical Science at the University of Warwick's School of Life Sciences, oversees the largest degree stream within the institution, catering to around 600 students. His unique background combines dual doctoral degrees in medicine and neurobiology, complemented by over 13 years of experience at the German Fraunhofer Society, Europe’s foremost organization for applied research.
His scientific pursuits are deeply rooted in the study of neurovascular disorders, with a particular focus on ischemic stroke and cerebral small vessel diseases that lead to cognitive decline. Dr. Boltze's research has significantly contributed to the development of cell therapies and acute cerebroprotective measures, emphasizing the impact of comorbidities like hypertension and dyslipidemia on therapeutic outcomes.
His approach to translational research includes the creation of an ovine model for focal cerebral ischemia, which has supported numerous acute and subacute studies featuring advanced brain imaging techniques. With an impressive record of over 190 peer-reviewed publications and 6 patents, Dr. Boltze’s contributions to the field are notable.
His leadership roles extend to his presidency of the International Symposium on Neuroprotection and Neurorepair and active participation in the Stroke Therapy Academic and Industry Roundtable since 2009, underscoring his dedication to advancing research in neurovascular disorders.
